Juvederm Vollure XC

Juvéderm Vollure XC features the same Vycross technology that Juvéderm Voluma XC (the filler used to plump the cheek area) and Juvéderm Volbella XC (the filler used in lip augmentation) uses. However, this time the Juvéderm Vollure XC is FDA-approved to use the Vycross technology in the nasolabial folds, which also happens to be the number-one dermal treatment area.

Filler risks and treatment limits

Dermal fillers can cause swelling, bruising, pain, infection, or nodules. Unintended injection into a blood vessel can cause tissue death, vision loss, or stroke. FDA approval is specific to a product and treatment area; it does not cover every facial area or body contouring. Ask which product is proposed, whether the use is approved, and how complications are managed.

Source: FDA dermal filler guidance.

Editorial update, October 2, 2026: AI-assisted edits use the linked sources to clarify patient information. This is not a clinician medical review or individual treatment advice.